Commercial City Clinic Department of Health
Durban, 4001, South Africa
NCT Number: NCT01452503
Evaluation of preference for three female condoms (FC).
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Durban, 4001, South Africa
The primary goal of this study was to identify the female condom most preferred by study participants. This provided USAID with data to make informed decisions regarding female condom purchases. The study was conducted in three parts. The objective of Part 1 was to familiarize each participant with the three FC types, to minimize learning curve effect in subsequent phases of study, and to gather information on participant demographics, FC acceptability, device function, safety, preference for each of the condom types, and use of male condoms during the same time period. The objective of Part 2 was to determine actual, "unstated" and "unbiased" preference for a particular type of FC. The objective of Part 3 was to identify reasons for preference of a particular FC type and to document details surrounding product use/non-use.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
comparison between 3 types of female condoms
comparison between 3 types of female condoms
comparison between 3 types of female condoms
Time frame: 3 months
The objective of Part 1 is to familiarize each participant with the use characteristics of the three female condom types in order to minimize learning curve effect in subsequent phases of study. In Part 2, a 'simulated market' will be created in order to determine an unbiased, free choice preference for a particular FC type. Part 3 will detail the reasons for participants' selection/preference of specific FC types.
Time frame: 3 months
safety measured by number of particpants with adverse events
Time frame: 3 Months
FC function measured by number of female condoms that failed during use (e.g. breakage, slippage and invagination) as self-reported by subjects through coital logs
FHI 360
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03282799
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kampala, Uganda
View Trial DetailsNCT03197961
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT03377608
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kampala, Uganda
View Trial DetailsNCT01594632
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Santo Domingo, Dominican Republic
View Trial Details